Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.53 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ALPL | P05186 | 1/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | ALPG | P10696 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | PLEC | Q15149 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 9/20 | 0.46 |
| ▸ | CA1 | P00915 | 7/20 | 0.46 |
| ▸ | CA2 | P00918 | 7/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | ALB | P02768 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CDC25A | P30304 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29415506 | 1.00 | USP2 (0.56) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL29399313 | 0.97 | USP2 (0.58) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL30179280 | 0.94 | USP2 (0.62) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL799734 | 0.94 | USP2 (0.62) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL31327372 | 0.94 | USP2 (0.50) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL3728723 | 0.88 | USP2 (0.57) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL15150533 | 0.87 | USP2 (0.60) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL18594982 | 0.87 | USP2 (0.51) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL20821271 | 0.86 | USP2 (0.55) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| 6-Carboxyfluorescein SCHEMBL9906208 | 0.85 | USP2 (0.69) | USP2L3MBTL1DNASE1L3PRMT1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570654-B2 | Nanoluc suicide substrates | PROMEGA CORPORATION (US) | 2026-03-10 | — | — | US | disclosed |
| US-20230382908-A1 | NANOLUC SUICIDE SUBSTRATES | PROMEGA CORPORATION | 2023-11-30 | — | — | US | disclosed |
| US-11655247-B2 | Nanoluc suicide substrates | PROMEGA CORPORATION (US) | 2023-05-23 | — | — | US | disclosed |
| US-20190337939-A1 | NANOLUC SUICIDE SUBSTRATES | PROMEGA CORPORATION | 2019-11-07 | — | — | US | disclosed |
| US-20190048344-A1 | CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION | ALNYLAM PHARMACEUTICALS INC (US) | 2019-02-14 | — | — | US | disclosed |
| US-20180362559-A1 | BONE ACTIVE NITROGEN-CONTAINING BISPHOSPHONATES WITH A NEAR INFRARED FLUORESCENT LABEL | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2018-12-20 | — | — | US | disclosed |
| EP-2806898-B1 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING VLA-4 | HOFFMANN LA ROCHE (CH) | 2018-07-18 | — | — | EP | disclosed |
| US-9845493-B2 | Tunable fluorescence using cleavable linkers | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-12-19 | — | — | US | disclosed |
| US-9845493-B2 | Tunable fluorescence using cleavable linkers | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-12-19 | — | — | US | disclosed |
| EP-2806897-B1 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING LFA-1 | HOFFMANN LA ROCHE (CH) | 2017-08-02 | — | — | EP | disclosed |
| US-20090163375-A1 | Use of Photopolymerization for Amplification and Detection of a Molecular Recognition Event | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2009-06-25 | — | — | US | disclosed |
| US-20090123372-A1 | DEVELOPMENT OF MOLECULAR IMAGING PROBES FOR CARBONIC ANHYDRASE-IX USING CLICK CHEMISTRY | SIEMENS MEDICAL SOLUTIONS USA, INC. | 2009-05-14 | — | — | US | disclosed |
| US-20090123372-A1 | DEVELOPMENT OF MOLECULAR IMAGING PROBES FOR CARBONIC ANHYDRASE-IX USING CLICK CHEMISTRY | SIEMENS MEDICAL SOLUTIONS USA, INC. | 2009-05-14 | — | — | US | disclosed |
| US-20090123372-A1 | DEVELOPMENT OF MOLECULAR IMAGING PROBES FOR CARBONIC ANHYDRASE-IX USING CLICK CHEMISTRY | SIEMENS MEDICAL SOLUTIONS USA, INC. | 2009-05-14 | — | — | US | disclosed |
| WO-2008124703-A2 | DEVELOPMENT OF MOLECULAR IMAGING PROBES FOR CARBONIC ANHYDRASE-IX USING CLICK CHEMISTRY | SIEMENS MEDICAL SOLUTIONS USA, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008124703-A2 | DEVELOPMENT OF MOLECULAR IMAGING PROBES FOR CARBONIC ANHYDRASE-IX USING CLICK CHEMISTRY | SIEMENS MEDICAL SOLUTIONS USA, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| US-7354706-B2 | Use of photopolymerization for amplification and detection of a molecular recognition event | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2008-04-08 | — | — | US | disclosed |
| US-7354706-B2 | Use of photopolymerization for amplification and detection of a molecular recognition event | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2008-04-08 | — | — | US | disclosed |
| US-20070243568-A1 | Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2007-10-18 | — | — | US | disclosed |
| US-20070243568-A1 | Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2007-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382908-A1 | NANOLUC SUICIDE SUBSTRATES | XIAP, NLN, BAD | USP2 1068/4885L3MBTL1 34/4885DNASE1L3 740/4885 |
| US-20190048344-A1 | CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION | DNMT1, LCK, MCTS1 | USP2 4435/4885L3MBTL1 301/4885DNASE1L3 2043/4885 |
| US-11655247-B2 | Nanoluc suicide substrates | XIAP, NLN, BAD | USP2 1068/4885L3MBTL1 34/4885DNASE1L3 740/4885 |
| US-20180362559-A1 | BONE ACTIVE NITROGEN-CONTAINING BISPHOSPHONATES WITH A NEAR INFRARED FLUORESCENT LABEL | PTH1R, BMP2, CALCR | USP2 4581/4885L3MBTL1 3272/4885DNASE1L3 1670/4885 |
| US-20090123372-A1 | DEVELOPMENT OF MOLECULAR IMAGING PROBES FOR CARBONIC ANHYDRASE-IX USING CLICK CHEMISTRY | CA9, CA4, CA13 | USP2 968/4885L3MBTL1 4705/4885DNASE1L3 2522/4885 |
| US-12570654-B2 | Nanoluc suicide substrates | NR3C1, LUC7L2, L3MBTL1 | USP2 2887/4885L3MBTL1 3/4885DNASE1L3 2676/4885 |
| US-20070243568-A1 | Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase | AGT, AGXT, AGTR1 | USP2 1746/4885L3MBTL1 32/4885DNASE1L3 1399/4885 |
| US-20190337939-A1 | NANOLUC SUICIDE SUBSTRATES | XIAP, NLN, BAD | USP2 1068/4885L3MBTL1 34/4885DNASE1L3 740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.